Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.89 billion.
Market Cap
1.23T
Revenue
109.89B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-37.62%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.72B | 4.80% | 782,672 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.68B | 2.51% | 264,112 | 14.92B |
| 3 | ARGX | argenx SE | 55.35B | 0.68% | 175,645 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.06B | 2.36% | 210,506 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 38.53B | 1.71% | 1,037,032 | - |
| 6 | RPRX | Royalty Pharma plc | 31.69B | 0.64% | 835,363 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.46B | 2.78% | 152,819 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 27.09B | 14.25% | 6,746,110 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.76B | 1.21% | 2,595,906 | 8.26M |
| 10 | INSM | Insmed Incorporated | 23.21B | 2.50% | 837,268 | 819.56M |
| 11 | INCY | Incyte Corporation | 22.95B | 6.83% | 1,102,578 | 5.36B |
| 12 | BNTX | BioNTech SE | 22.78B | 0.10% | 194,544 | 3.23B |
| 13 | ASND | Ascendis Pharma A/S | 16.38B | 0.81% | 333,581 | 998.25M |
| 14 | GMAB | Genmab A/S | 16.10B | -0.06% | 906,994 | 3.90B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | 1.96% | 137,510 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.01B | 2.65% | 1,516,638 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.79B | 3.04% | 538,294 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.47B | 4.01% | 1,232,156 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.68B | 3.83% | 416,155 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.13B | 2.36% | 86,335 | 1.13B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.54B | 4.12% | 607,021 | 3.24B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.49B | 2.86% | 462,639 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 11.28B | 2.82% | 1,107,954 | 105.82M |
| 24 | TECH | Bio-Techne Corporation | 11.10B | 0.31% | 4,794,942 | 1.21B |
| 25 | SMMT | Summit Therapeutics Inc. | 10.94B | -0.56% | 921,019 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 10.92B | 2.91% | 83,210 | 417.30M |
| 27 | APGE | Apogee Therapeutics, Inc. | 9.94B | -0.01% | 2,303,030 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.76B | 0.05% | 538,941 | - |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.43B | -1.53% | 530,678 | 51.48M |
| 30 | CORT | Corcept Therapeutics Incorporated | 9.35B | 2.77% | 183,790 | 769.10M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.15B | 0.06% | 276,616 | 7.46M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.03B | 4.86% | 675,338 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 8.60B | 5.46% | 5,377,287 | 140.98M |
| 34 | PCVX | Vaxcyte, Inc. | 8.15B | 5.12% | 675,558 | - |
| 35 | IMVT | Immunovant, Inc. | 7.90B | 0.58% | 240,714 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 7.84B | -0.60% | 156,597 | 74.06M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.78B | 2.33% | 566,146 | 700.35M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.65B | -0.64% | 408,785 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.58B | 2.19% | 236,121 | 217.17M |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 7.53B | 5.34% | 455,619 | 569.61M |
| 41 | ABVX | ABIVAX Société Anonyme | 7.30B | 3.86% | 731,763 | 5.67M |
| 42 | PTCT | PTC Therapeutics, Inc. | 7.10B | 1.30% | 570,257 | 827.11M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.54B | 1.51% | 699,885 | - |
| 44 | CGON | CG Oncology, Inc. | 6.42B | -0.01% | 279,649 | 5.07M |
| 45 | COGT | Cogent Biosciences, Inc. | 6.40B | -1.54% | 772,768 | - |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 5.97B | 0.69% | 113,170 | 274.48M |
| 47 | BLTE | Belite Bio, Inc | 5.91B | 0.25% | 90,066 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.64B | 2.82% | 549,987 | 7.50M |
| 49 | TVTX | Travere Therapeutics, Inc. | 5.55B | 1.19% | 391,643 | 536.20M |
| 50 | CAI | Caris Life Sciences, Inc. | 5.51B | 4.17% | 1,034,825 | 907.29M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.37B | 3.18% | 731,900 | 4.10M |
| 52 | LEGN | Legend Biotech Corporation | 5.27B | -0.25% | 639,694 | 1.14B |
| 53 | ORKA | Oruka Therapeutics, Inc. | 5.19B | -0.62% | 452,542 | - |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 5.17B | 3.19% | 443,494 | 1.34M |
| 55 | MANE | Veradermics, Incorporated | 5.08B | 1.77% | 229,044 | - |
| 56 | CELC | Celcuity Inc. | 4.92B | 5.11% | 312,860 | - |
| 57 | DFTX | Definium Therapeutics, Inc. | 4.91B | 0.42% | 1,500,619 | - |
| 58 | ERAS | Erasca, Inc. | 4.69B | 0.94% | 1,614,042 | - |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.66B | 14.71% | 2,402,661 | 1.10B |
| 60 | TNGX | Tango Therapeutics, Inc. | 4.48B | 2.65% | 2,091,940 | 56.99M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.46B | -0.47% | 153,796 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 4.44B | 3.27% | 1,297,576 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.03B | 3.65% | 1,387,477 | 10.68M |
| 64 | DNLI | Denali Therapeutics Inc. | 4.01B | 2.18% | 608,538 | - |
| 65 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | 5.09% | 1,123,587 | 18.07M |
| 66 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.02% | 370,703 | 596.96M |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.84B | 0.88% | 449,397 | 236.00M |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.84B | 3.45% | 354,256 | 22.57M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.60B | -1.47% | 27,868 | 803.79M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.57B | 6.30% | 113,203 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 3.56B | 5.31% | 1,032,834 | 164.01M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.54B | 3.83% | 1,399,520 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.52B | 2.76% | 194,985 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.40B | 1.84% | 373,850 | 415.62M |
| 75 | ALMS | Alumis Inc. | 3.35B | 4.95% | 547,608 | 8.40M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 3.24B | 1.76% | 696,843 | 225.27M |
| 77 | VERA | Vera Therapeutics, Inc. | 3.06B | 5.09% | 672,090 | - |
| 78 | ELVN | Enliven Therapeutics, Inc. | 3.02B | 0.83% | 631,022 | - |
| 79 | RARE | Ultragenyx Pharmaceutical Inc. | 3.01B | 4.79% | 630,789 | 670.00M |
| 80 | QURE | uniQure N.V. | 3.01B | -2.87% | 1,149,570 | 18.09M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.83B | 2.40% | 245,678 | 535.08M |
| 82 | IRON | Disc Medicine, Inc. | 2.77B | 3.46% | 254,079 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.72B | 1.67% | 206,981 | 865.00K |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.68B | 0.24% | 143,874 | - |
| 85 | TRVI | Trevi Therapeutics, Inc. | 2.56B | 0.06% | 791,898 | - |
| 86 | MBX | MBX Biosciences, Inc. | 2.53B | 5.58% | 253,279 | - |
| 87 | BHVN | Biohaven Ltd. | 2.49B | 7.95% | 2,324,376 | - |
| 88 | NRIX | Nurix Therapeutics, Inc. | 2.39B | 2.98% | 997,662 | 71.78M |
| 89 | NTLA | Intellia Therapeutics, Inc. | 2.36B | 5.55% | 1,785,051 | 66.09M |
| 90 | PHVS | Pharvaris N.V. | 2.35B | 1.02% | 173,140 | - |
| 91 | IMNM | Immunome, Inc. | 2.29B | 4.33% | 430,233 | 4.02M |
| 92 | VCEL | Vericel Corporation | 2.27B | 3.52% | 246,371 | 292.09M |
| 93 | SLS | SELLAS Life Sciences Group, Inc. | 2.24B | 14.43% | 7,628,235 | - |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | -1.31% | 476,027 | 298.30M |
| 95 | KOD | Kodiak Sciences Inc. | 2.23B | 4.63% | 228,668 | - |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.20B | 2.82% | 526,257 | 52.04M |
| 97 | AGIO | Agios Pharmaceuticals, Inc. | 2.19B | 1.88% | 267,499 | 66.05M |
| 98 | ABCL | AbCellera Biologics Inc. | 2.19B | 7.51% | 5,318,556 | 79.21M |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 2.14B | -1.54% | 403,146 | - |
| 100 | NKTR | Nektar Therapeutics | 2.13B | 1.70% | 252,507 | 55.63M |
| 101 | GENB | Generate Biomedicines, Inc. | 2.12B | 0.67% | 297,285 | 30.30M |
| 102 | PGEN | Precigen, Inc. | 2.06B | 4.71% | 2,125,174 | 31.60M |
| 103 | KARD | Kardigan, Inc. | 2.05B | 1.64% | 200,078 | - |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 3.55% | 180,016 | 899.11M |
| 105 | ADMA | ADMA Biologics, Inc. | 2.04B | 0.80% | 436,409 | 509.86M |
| 106 | STOK | Stoke Therapeutics, Inc. | 2.02B | 6.92% | 510,658 | 32.08M |
| 107 | PVLA | Palvella Therapeutics, Inc. | 2.01B | 2.79% | 171,061 | - |
| 108 | ZLAB | Zai Lab Limited | 1.98B | -4.86% | 933,921 | 453.28M |
| 109 | NUVB | Nuvation Bio Inc. | 1.98B | -2.15% | 13,118,896 | 143.05M |
| 110 | VRDN | Viridian Therapeutics, Inc. | 1.98B | 2.93% | 390,769 | 70.92M |
| 111 | IOVA | Iovance Biotherapeutics, Inc. | 1.96B | 4.16% | 3,816,307 | 285.61M |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | 8.23% | 9,649,442 | 66.41M |
| 113 | ATAI | AtaiBeckley Inc. | 1.92B | 13.76% | 6,973,818 | 3.49M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.91B | -0.96% | 185,004 | - |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.26% | 153,130 | - |
| 116 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 1.73% | 52,840 | 1.20B |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.89B | 1.57% | 157,275 | 20.00M |
| 118 | GHRS | GH Research PLC | 1.82B | 4.66% | 52,432 | - |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 3.28% | 416,152 | 217.17M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.81B | -1.20% | 310,447 | 42.95M |
| 121 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | 0.81% | 926,934 | 7.47M |
| 122 | BCAX | Bicara Therapeutics Inc. | 1.77B | 2.28% | 406,299 | - |
| 123 | ANAB | AnaptysBio, Inc. | 1.77B | 1.88% | 62,666 | 232.39M |
| 124 | ABSI | Absci Corporation | 1.77B | 11.07% | 5,579,034 | 1.84M |
| 125 | ZYME | Zymeworks Inc. | 1.77B | 1.81% | 76,786 | 81.26M |
| 126 | INVA | Innoviva, Inc. | 1.75B | 1.63% | 86,181 | 420.69M |
| 127 | SRPT | Sarepta Therapeutics, Inc. | 1.74B | 2.93% | 815,693 | 2.18B |
| 128 | VIR | Vir Biotechnology, Inc. | 1.73B | 4.05% | 408,908 | 65.50M |
| 129 | NBTX | Nanobiotix S.A. | 1.73B | 4.47% | 12,576 | 38.27M |
| 130 | URGN | UroGen Pharma Ltd. | 1.70B | 1.75% | 106,715 | 140.49M |
| 131 | MESO | Mesoblast Limited | 1.69B | -8.55% | 221,421 | 65.38M |
| 132 | AKTS | Aktis Oncology, Inc. | 1.67B | -3.02% | 225,406 | 8.28M |
| 133 | SEPN | Septerna, Inc. | 1.67B | 7.06% | 189,441 | 72.26M |
| 134 | FTRE | Fortrea Holdings Inc. | 1.64B | -2.34% | 420,569 | 2.71B |
| 135 | AVBP | ArriVent BioPharma, Inc. | 1.59B | 0.77% | 173,449 | - |
| 136 | IMCR | Immunocore Holdings plc | 1.58B | 1.87% | 139,992 | 412.81M |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.57B | 0.69% | 320,910 | 10.00M |
| 138 | CAPR | Capricor Therapeutics, Inc. | 1.57B | -11.09% | 1,327,817 | 11.13M |
| 139 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -1.14% | 758,326 | 204.73M |
| 140 | SVRA | Savara Inc. | 1.56B | 1.82% | 1,010,517 | - |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.54B | 3.26% | 469,297 | 20.00M |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.50B | 3.61% | 154,386 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.49B | 1.38% | 306,657 | - |
| 144 | ARDX | Ardelyx, Inc. | 1.49B | -0.41% | 3,611,202 | 427.68M |
| 145 | COAG | Hemab Therapeutics Holdings, Inc. | 1.46B | 12.99% | 66,941 | - |
| 146 | NVAX | Novavax, Inc. | 1.46B | 3.62% | 1,165,955 | 596.34M |
| 147 | AAPG | Ascentage Pharma Group International | 1.43B | -1.76% | 174,182 | 82.08M |
| 148 | DMRA | Damora Therapeutics, Inc. | 1.42B | 1.99% | 154,656 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.38B | -1.57% | 103,934 | 1.30M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.35B | 5.00% | 34,947 | - |
| 151 | IMTX | Immatics N.V. | 1.31B | 0.68% | 77,510 | 43.00M |
| 152 | JBIO | Jade Biosciences, Inc. | 1.28B | -0.87% | 225,875 | - |
| 153 | MNKD | MannKind Corporation | 1.28B | 5.34% | 1,735,972 | 360.78M |
| 154 | EYPT | EyePoint, Inc. | 1.17B | 1.75% | 223,471 | 7.61M |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 1.15B | 0.95% | 294,399 | - |
| 156 | XNCR | Xencor, Inc. | 1.15B | 4.88% | 388,266 | 97.36M |
| 157 | WVE | Wave Life Sciences Ltd. | 1.14B | 3.48% | 523,443 | 71.80M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 0.92% | 204,566 | - |
| 159 | MGTX | MeiraGTx Holdings plc | 1.10B | 3.47% | 162,856 | 79.76M |
| 160 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.09B | 6.77% | 2,123,198 | 69.64M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.08B | 4.62% | 30,953 | - |
| 162 | SANA | Sana Biotechnology, Inc. | 1.05B | 7.36% | 1,082,945 | - |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 996.63M | -0.17% | 910,836 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 991.70M | 1.27% | 394,062 | - |
| 165 | DRTS | Alpha Tau Medical Ltd. | 981.12M | -2.60% | 247,302 | - |
| 166 | DBVT | DBV Technologies S.A. | 950.00M | 2.37% | 51,876 | 5.74M |
| 167 | AVTX | Avalo Therapeutics, Inc. | 949.33M | 0.33% | 464,375 | 59.00K |
| 168 | KURA | Kura Oncology, Inc. | 944.56M | 2.70% | 313,484 | 71.64M |
| 169 | PHAR | Pharming Group N.V. | 941.11M | -0.58% | 2,443 | 369.49M |
| 170 | JANX | Janux Therapeutics, Inc. | 923.30M | 3.84% | 1,108,232 | 13.73M |
| 171 | LBRX | LB Pharmaceuticals Inc | 917.37M | 3.19% | 169,585 | - |
| 172 | ANRO | Alto Neuroscience, Inc. | 916.30M | 3.20% | 86,512 | - |
| 173 | SLDB | Solid Biosciences Inc. | 914.60M | 4.85% | 395,064 | - |
| 174 | REPL | Replimune Group, Inc. | 909.12M | -1.08% | 3,612,938 | - |
| 175 | ABUS | Arbutus Biopharma Corporation | 906.70M | 4.08% | 1,098,433 | 191.45M |
| 176 | EVMN | Evommune, Inc. | 898.30M | 3.36% | 227,978 | 10.00M |
| 177 | TBPH | Theravance Biopharma, Inc. | 893.41M | -0.35% | 113,056 | 109.78M |
| 178 | GERN | Geron Corporation | 888.51M | 1.09% | 3,989,971 | 196.12M |
| 179 | ANNX | Annexon, Inc. | 881.47M | 4.47% | 1,345,293 | - |
| 180 | ODTX | Odyssey Therapeutics, Inc. | 878.08M | 3.03% | 39,835 | 1.06M |
| 181 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | 6.73% | 1,411,145 | 98.99M |
| 182 | VOR | Vor Biopharma Inc. | 845.30M | 4.49% | 589,837 | - |
| 183 | DSGN | Design Therapeutics, Inc. | 829.43M | -1.19% | 192,394 | - |
| 184 | PHAT | Phathom Pharmaceuticals, Inc. | 817.34M | -0.48% | 301,467 | 204.89M |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 811.06M | 3.70% | 298,593 | 122.29M |
| 186 | AURA | Aura Biosciences, Inc. | 772.10M | 2.04% | 93,504 | - |
| 187 | ALLO | Allogene Therapeutics, Inc. | 733.45M | 3.16% | 2,454,578 | 22.00K |
| 188 | CTMX | CytomX Therapeutics, Inc. | 726.04M | 1.99% | 561,699 | 35.54M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 723.34M | 5.69% | 72,842 | 299.77M |
| 190 | OCS | Oculis Holding AG | 719.83M | 1.53% | 78,042 | 1.40M |
| 191 | CLYM | Climb Bio, Inc. | 719.48M | -0.75% | 176,121 | - |
| 192 | CADL | Candel Therapeutics, Inc. | 711.45M | 2.53% | 664,065 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 708.01M | 4.65% | 440,598 | - |
| 194 | IVA | Inventiva S.A. | 703.47M | 1.00% | 466,754 | 7.94M |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 695.53M | 1.43% | 1,063,205 | 8.37M |
| 196 | IMMX | Immix Biopharma, Inc. | 694.81M | 0.41% | 801,073 | - |
| 197 | TENX | Tenax Therapeutics, Inc. | 688.21M | 4.50% | 424,249 | - |
| 198 | NVCT | Nuvectis Pharma, Inc. | 677.20M | -8.40% | 413,101 | - |
| 199 | SGP | SpyGlass Pharma, Inc. | 658.14M | 4.65% | 21,615 | - |
| 200 | DNA | Ginkgo Bioworks Holdings, Inc. | 657.82M | 5.22% | 297,695 | 151.40M |
| 201 | AGMB | AgomAb Therapeutics NV | 653.77M | -1.15% | 50,604 | - |
| 202 | FTH | Faeth Therapeutics, Inc. | 639.31M | 0.53% | 65,695 | - |
| 203 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 634.45M | 2.99% | 142,904 | - |
| 204 | DRUG | Bright Minds Biosciences Inc. | 630.86M | 2.81% | 49,576 | - |
| 205 | OMER | Omeros Corporation | 626.77M | -19.22% | 4,403,307 | 9.89M |
| 206 | SLBT | SL Science Holding Limited | 614.18M | -9.31% | 28,529 | - |
| 207 | FDMT | 4D Molecular Therapeutics, Inc. | 608.23M | 1.00% | 235,662 | 88.24M |
| 208 | PRME | Prime Medicine, Inc. | 606.87M | 5.66% | 1,447,458 | 4.03M |
| 209 | CRMD | CorMedix Inc. | 601.73M | -0.65% | 567,187 | 400.05M |
| 210 | ACHV | Achieve Life Sciences, Inc. | 597.99M | 2.19% | 593,886 | - |
| 211 | EIKN | Eikon Therapeutics, Inc. | 596.07M | 11.78% | 68,405 | - |
| 212 | MDXG | MiMedx Group, Inc. | 592.06M | 4.33% | 285,093 | 389.42M |
| 213 | CBIO | Crescent Biopharma, Inc. | 590.15M | 4.53% | 31,610 | 11.88M |
| 214 | MNPR | Monopar Therapeutics Inc. | 584.54M | -0.42% | 102,183 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 583.91M | -0.27% | 37,459 | - |
| 216 | GYRE | Gyre Therapeutics, Inc. | 583.41M | 2.49% | 24,449 | 117.05M |
| 217 | TRAX | First Tracks Biotherapeutics, Inc. | 556.53M | -2.57% | 82,841 | - |
| 218 | RGNX | REGENXBIO Inc. | 554.20M | 4.69% | 639,824 | 87.82M |
| 219 | ALT | Altimmune, Inc. | 549.39M | -1.57% | 1,184,827 | 36.00K |
| 220 | PROK | ProKidney Corp. | 546.73M | 6.47% | 387,372 | 889.00K |
| 221 | RZLT | Rezolute, Inc. | 529.65M | 0.80% | 593,549 | - |
| 222 | XOMA | XOMA Royalty Corporation | 528.60M | -0.12% | 19,354 | 48.56M |
| 223 | ARVN | Arvinas, Inc. | 527.14M | 1.74% | 314,317 | 89.40M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 514.94M | 3.29% | 252,572 | - |
| 225 | CTNM | Contineum Therapeutics, Inc. | 512.94M | 2.69% | 89,231 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 511.88M | 6.47% | 75,148 | 71.10M |
| 227 | PRTA | Prothena Corporation plc | 510.44M | 5.18% | 159,638 | 57.94M |
| 228 | CCCC | C4 Therapeutics, Inc. | 503.08M | 3.41% | 1,708,836 | 34.86M |
| 229 | OCGN | Ocugen, Inc. | 499.32M | 7.66% | 3,484,964 | 4.47M |
| 230 | STRO | Sutro Biopharma, Inc. | 497.11M | 1.52% | 77,992 | 99.61M |
| 231 | ZURA | Zura Bio Limited | 496.84M | 15.20% | 520,312 | - |
| 232 | SLN | Silence Therapeutics plc | 495.01M | 4.80% | 349,794 | 839.00K |
| 233 | NGNE | Neurogene Inc. | 491.60M | 2.30% | 74,134 | 925.00K |
| 234 | OVID | Ovid Therapeutics Inc. | 483.40M | 7.02% | 617,088 | 7.12M |
| 235 | CABA | Cabaletta Bio, Inc. | 482.64M | 1.37% | 1,600,210 | - |
| 236 | VALN | Valneva SE | 474.76M | -0.19% | 12,002 | 180.25M |
| 237 | FBRX | Forte Biosciences, Inc. | 470.39M | 2.89% | 33,138 | - |
| 238 | VTVT | vTv Therapeutics Inc. | 462.50M | 1.22% | 24,726 | 36.84M |
| 239 | STTK | Shattuck Labs, Inc. | 460.85M | 1.69% | 307,813 | 1.00M |
| 240 | ARTV | Artiva Biotherapeutics, Inc. | 443.12M | 3.28% | 95,771 | 251.00K |
| 241 | BNTC | Benitec Biopharma Inc. | 438.02M | -1.92% | 71,388 | - |
| 242 | AUTL | Autolus Therapeutics plc | 437.81M | 3.46% | 290,664 | 92.62M |
| 243 | IPSC | Century Therapeutics, Inc. | 435.56M | 5.00% | 651,944 | 109.16M |
| 244 | EDIT | Editas Medicine, Inc. | 435.06M | 3.47% | 792,273 | 38.69M |
| 245 | SGMT | Sagimet Biosciences Inc. | 431.03M | 1.75% | 133,337 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 419.79M | 1.25% | 388,877 | - |
| 247 | PBYI | Puma Biotechnology, Inc. | 417.38M | 6.91% | 48,433 | 227.18M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 412.04M | 5.35% | 42,417 | 69.21M |
| 249 | PRLD | Prelude Therapeutics Incorporated | 410.59M | 0.98% | 63,943 | 16.72M |
| 250 | ANL | Adlai Nortye Ltd. | 402.40M | -0.98% | 35,604 | 5.00M |
| 251 | INDP | Indaptus Therapeutics, Inc. | 400.88M | 8.59% | 43,979 | - |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 398.97M | 6.02% | 203,838 | 9.01M |
| 253 | CMPX | Compass Therapeutics, Inc. | 380.89M | 2.17% | 968,082 | 850.00K |
| 254 | LXEO | Lexeo Therapeutics, Inc. | 375.73M | 1.81% | 137,988 | - |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 368.56M | 0.57% | 34,810 | 51.00M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 363.61M | 2.78% | 751,425 | - |
| 257 | OABI | OmniAb, Inc. | 362.43M | -0.40% | 132,315 | 28.94M |
| 258 | UPB | Upstream Bio, Inc. | 360.80M | 4.25% | 84,969 | 3.32M |
| 259 | LRMR | Larimar Therapeutics, Inc. | 360.12M | -1.43% | 1,069,250 | - |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 359.72M | 3.33% | 58,169 | - |
| 261 | VNDA | Vanda Pharmaceuticals Inc. | 359.61M | 2.22% | 205,749 | 217.78M |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 347.01M | 4.72% | 34,708 | - |
| 263 | IRD | Opus Genetics, Inc. | 332.09M | 9.68% | 374,836 | 11.98M |
| 264 | GALT | Galectin Therapeutics Inc. | 327.31M | 17.49% | 434,410 | - |
| 265 | HELP | Cybin Inc. | 327.23M | 8.64% | 1,453,483 | - |
| 266 | IKT | Inhibikase Therapeutics, Inc. | 324.65M | 1.87% | 196,350 | 1.00 |
| 267 | ABEO | Abeona Therapeutics Inc. | 323.73M | 2.16% | 532,159 | 14.54M |
| 268 | VSTM | Verastem, Inc. | 322.50M | 6.38% | 1,120,078 | 49.59M |
| 269 | PALI | Palisade Bio, Inc. | 321.99M | 3.06% | 1,033,736 | - |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 309.13M | 1.64% | 333,549 | 14.78M |
| 271 | MGNX | MacroGenics, Inc. | 302.24M | 2.04% | 167,633 | 157.08M |
| 272 | IMRX | Immuneering Corporation | 300.84M | 2.65% | 318,233 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 300.50M | 1.55% | 65,333 | 114.70K |
| 274 | NMRA | Neumora Therapeutics, Inc. | 296.45M | 5.96% | 634,496 | - |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 294.52M | 4.38% | 600,080 | - |
| 276 | LYEL | Lyell Immunopharma, Inc. | 291.21M | -0.08% | 11,192 | 31.00K |
| 277 | SRZN | Surrozen, Inc. | 290.90M | 2.18% | 15,637 | 7.49M |
| 278 | ADAG | Adagene Inc. | 288.74M | 6.07% | 151,490 | 7.67M |
| 279 | BCYC | Bicycle Therapeutics plc | 288.32M | 2.99% | 176,375 | 63.50M |
| 280 | GLSI | Greenwich LifeSciences, Inc. | 285.12M | 5.97% | 95,110 | - |
| 281 | CNXU | Conexeu Sciences Inc. | 283.91M | 3.82% | 11,105 | - |
| 282 | IFRX | InflaRx N.V. | 281.33M | 2.69% | 292,849 | 33.82K |
| 283 | NAUT | Nautilus Biotechnology, Inc. | 278.30M | -3.52% | 551,158 | - |
| 284 | ZNTL | Zentalis Pharmaceuticals, Inc. | 273.71M | 1.45% | 454,802 | 26.87M |
| 285 | RNAC | Cartesian Therapeutics, Inc. | 273.10M | 4.09% | 42,095 | 1.78M |
| 286 | TRDA | Entrada Therapeutics, Inc. | 271.87M | 5.52% | 49,941 | 5.74M |
| 287 | NAGE | Niagen Bioscience, Inc. | 270.96M | 2.57% | 572,794 | 130.42M |
| 288 | IVVD | Invivyd, Inc. | 262.58M | 1.42% | 414,020 | 55.87M |
| 289 | ARMP | Armata Pharmaceuticals, Inc. | 255.69M | 7.15% | 54,356 | 5.20M |
| 290 | ACIU | AC Immune SA | 251.97M | 3.67% | 47,136 | 4.62M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 251.63M | 4.47% | 187,400 | - |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 246.71M | 5.64% | 183,723 | 32.72M |
| 293 | FULC | Fulcrum Therapeutics, Inc. | 244.54M | 1.66% | 341,114 | 80.00M |
| 294 | FHTX | Foghorn Therapeutics Inc. | 242.78M | 2.61% | 70,266 | 28.22M |
| 295 | AVXL | Anavex Life Sciences Corp. | 242.34M | 6.09% | 274,356 | - |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 237.69M | 0.06% | 5,205 | 18.47M |
| 297 | FATE | Fate Therapeutics, Inc. | 234.87M | 7.75% | 1,510,859 | 6.32M |
| 298 | CHRS | Coherus Oncology, Inc. | 233.69M | 2.36% | 162,845 | 46.88M |
| 299 | TARA | Protara Therapeutics, Inc. | 226.50M | 0.75% | 216,933 | - |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 225.89M | 2.19% | 84,836 | 7.15M |
| 301 | KPTI | Karyopharm Therapeutics Inc. | 224.82M | 4.86% | 173,680 | 151.12M |
| 302 | RNA | Atrium Therapeutics, Inc. | 220.66M | 0.94% | 45,762 | 36.68M |
| 303 | CDXS | Codexis, Inc. | 218.61M | 6.89% | 302,958 | 78.09M |
| 304 | CAMP | Camp4 Therapeutics Corporation | 218.09M | 7.14% | 62,333 | 3.93M |
| 305 | OTLK | Outlook Therapeutics, Inc. | 216.35M | 11.18% | 5,606,185 | 333.14K |
| 306 | ALEC | Alector, Inc. | 215.39M | 4.86% | 123,833 | 18.42M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 214.19M | -0.14% | 142,708 | 36.49M |
| 308 | QTTB | Q32 Bio Inc. | 212.12M | 4.69% | 200,121 | 53.74M |
| 309 | KROS | Keros Therapeutics, Inc. | 208.01M | 0.96% | 63,079 | 33.18M |
| 310 | IMUX | Immunic, Inc. | 207.23M | 0.95% | 146,575 | - |
| 311 | NGEN | NervGen Pharma Corp. | 204.97M | 1.05% | 288,749 | - |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 203.51M | 4.99% | 121,117 | 54.71M |
| 313 | CNTN | Canton Strategic Holdings, Inc. | 201.04M | 7.26% | 136,907 | - |
| 314 | ORMP | Oramed Pharmaceuticals Inc. | 200.54M | -2.00% | 121,314 | 2.00M |
| 315 | NKTX | Nkarta, Inc. | 199.61M | 0.36% | 222,563 | - |
| 316 | CLLS | Cellectis S.A. | 199.19M | 1.73% | 3,451 | 75.11M |
| 317 | CGEN | Compugen Ltd. | 197.21M | 3.22% | 108,170 | 72.66M |
| 318 | NERV | Minerva Neurosciences, Inc. | 194.51M | 1.58% | 31,019 | - |
| 319 | UNCY | Unicycive Therapeutics, Inc. | 193.84M | -11.57% | 1,917,209 | - |
| 320 | TTRX | Turn Therapeutics Inc. | 193.62M | -4.69% | 10,920 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.04M | 1.09% | 140,537 | 17.56M |
| 322 | MDWD | MediWound Ltd. | 192.27M | 2.54% | 5,935 | 14.48M |
| 323 | EQ | Equillium, Inc. | 189.05M | 1.36% | 81,777 | 4.39M |
| 324 | ANTX | AN2 Therapeutics, Inc. | 188.00M | 1.56% | 93,568 | - |
| 325 | NBP | NovaBridge Biosciences | 186.77M | 0.94% | 57,377 | - |
| 326 | KRRO | Korro Bio, Inc. | 186.63M | 6.33% | 45,169 | 3.84M |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 186.12M | 4.05% | 269,854 | 76.38M |
| 328 | DTIL | Precision BioSciences, Inc. | 181.39M | 4.15% | 91,622 | 45.07M |
| 329 | LENZ | LENZ Therapeutics, Inc. | 180.91M | 4.72% | 276,521 | 20.99M |
| 330 | YDES | YD Bio Limited | 179.32M | 5.37% | 8,536 | 510.36K |
| 331 | MIST | Milestone Pharmaceuticals Inc. | 170.74M | 0.40% | 310,349 | 1.78M |
| 332 | IPHA | Innate Pharma S.A. | 169.63M | 2.51% | 4,937 | 10.57M |
| 333 | PYXS | Pyxis Oncology, Inc. | 169.16M | 19.73% | 5,024,538 | 13.86M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 168.29M | 5.43% | 126,001 | - |
| 335 | OKUR | OnKure Therapeutics, Inc. | 167.64M | -1.66% | 46,423 | - |
| 336 | HUMA | Humacyte, Inc. | 166.91M | 21.26% | 14,938,523 | 2.02M |
| 337 | CRBU | Caribou Biosciences, Inc. | 166.62M | 7.01% | 539,663 | 11.20M |
| 338 | PRQR | ProQR Therapeutics N.V. | 164.89M | - | 756,556 | 15.73M |
| 339 | KZIA | Kazia Therapeutics Limited | 160.89M | 1.15% | 31,792 | 1.27M |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 160.45M | 4.97% | 86,669 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 159.49M | 3.52% | 582,698 | 225.00K |
| 342 | HURA | TuHURA Biosciences, Inc. | 157.93M | -4.25% | 69,422 | - |
| 343 | TLSA | Tiziana Life Sciences Ltd | 150.64M | 3.10% | 88,150 | - |
| 344 | SPRB | Spruce Biosciences, Inc. | 150.00M | 3.28% | 23,653 | 697.00K |
| 345 | MOLN | Molecular Partners AG | 147.39M | -4.58% | 3,686 | 856.30K |
| 346 | MENS | Jyong Biotech Ltd. | 146.24M | 3.68% | 109,221 | - |
| 347 | ACOG | Alpha Cognition Inc. | 140.77M | -0.54% | 156,335 | 10.83M |
| 348 | NRXP | NRx Pharmaceuticals, Inc. | 139.17M | 8.01% | 376,277 | 2.29M |
| 349 | ENLV | Enlivex Ltd. | 137.35M | -1.84% | 124,083 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 136.63M | 4.83% | 261,691 | 233.00K |
| 351 | ADCT | ADC Therapeutics SA | 134.19M | 1.44% | 210,604 | 79.18M |
| 352 | GNLX | Genelux Corporation | 129.23M | 0.34% | 53,548 | 8.00K |
| 353 | AGEN | Agenus Inc. | 127.43M | 6.25% | 217,338 | 123.87M |
| 354 | COYA | Coya Therapeutics, Inc. | 123.74M | 2.83% | 112,285 | 7.94M |
| 355 | GUTS | Fractyl Health, Inc. | 123.27M | -2.74% | 315,362 | 3.00K |
| 356 | SPRO | Spero Therapeutics, Inc. | 122.75M | 4.95% | 292,583 | 61.19M |
| 357 | PEPG | PepGen Inc. | 120.35M | 1.75% | 75,794 | - |
| 358 | ENGN | enGene Therapeutics Inc. | 118.24M | -0.28% | 371,009 | - |
| 359 | PLYX | Polaryx Therapeutics, Inc. | 116.46M | 6.49% | 59,849 | - |
| 360 | NTHI | NeOnc Technologies Holdings, Inc. | 114.30M | 0.11% | 9,831 | 39.99K |
| 361 | AARD | Aardvark Therapeutics, Inc. | 113.45M | 2.77% | 144,463 | - |
| 362 | ONCY | Oncolytics Biotech Inc. | 113.39M | 3.23% | 354,426 | - |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 107.07M | -1.39% | 320,728 | - |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 106.17M | -0.48% | 13,596 | 37.16M |
| 365 | CUE | Cue Biopharma, Inc. | 105.96M | 2.55% | 23,907 | 32.73M |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 104.92M | 2.56% | 13,454 | - |
| 367 | CGTX | Cognition Therapeutics, Inc. | 104.71M | 3.54% | 502,267 | - |
| 368 | CBUS | Cibus, Inc. | 103.81M | 1.49% | 106,342 | 4.29M |
| 369 | VANI | Vivani Medical, Inc. | 103.41M | 5.19% | 50,518 | - |
| 370 | ALPS | Alps Group Inc | 102.75M | -5.00% | 46,763 | 3.74M |
| 371 | PTHS | Pelthos Therapeutics Inc. | 99.07M | -2.41% | 2,086 | 27.70M |
| 372 | BDTX | Black Diamond Therapeutics, Inc. | 98.56M | 1.18% | 463,838 | 70.00M |
| 373 | FBIO | Fortress Biotech, Inc. | 98.49M | -1.82% | 303,514 | 66.16M |
| 374 | SEER | Seer, Inc. | 95.67M | 0.58% | 53,721 | 15.17M |
| 375 | BMEA | Biomea Fusion, Inc. | 95.07M | 6.91% | 845,188 | - |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 94.75M | 3.03% | 130,229 | 3.17M |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 93.62M | 1.66% | 11,404 | 23.14M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 93.04M | 1.22% | 3,357 | - |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 90.91M | 2.31% | 432,537 | 65.34K |
| 380 | PYPD | PolyPid Ltd. | 90.12M | 2.84% | 54,744 | - |
| 381 | NRXS | NeurAxis, Inc. | 89.42M | 4.49% | 22,427 | 4.28M |
| 382 | ANIX | Anixa Biosciences, Inc. | 89.14M | - | 787,961 | - |
| 383 | ICCC | ImmuCell Corporation | 88.75M | -0.81% | 11,523 | 29.93M |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 86.66M | 2.44% | 17,714 | - |
| 385 | RNTX | Rein Therapeutics Inc. | 86.04M | -1.13% | 58,184 | - |
| 386 | RLYB | Rallybio Corporation | 85.83M | 3.12% | 44,019 | 858.00K |
| 387 | ATHE | Alterity Therapeutics Limited | 85.78M | -1.02% | 8,670 | 4.43M |
| 388 | ACET | Adicet Bio, Inc. | 85.32M | 2.85% | 33,717 | - |
| 389 | LIXT | Lixte Biotechnology Holdings, Inc. | 85.07M | 3.31% | 45,118 | - |
| 390 | CSBR | Champions Oncology, Inc. | 84.99M | 0.66% | 4,958 | 57.95M |
| 391 | CRDF | Cardiff Oncology, Inc. | 84.44M | 2.07% | 289,023 | 525.00K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 84.21M | 2.59% | 42,306 | - |
| 393 | GOSS | Gossamer Bio, Inc. | 82.37M | 2.00% | 4,745,362 | 55.54M |
| 394 | IBIO | iBio, Inc. | 81.97M | 3.77% | 647,654 | 300.00K |
| 395 | OKYO | OKYO Pharma Limited | 81.87M | 1.30% | 15,182 | - |
| 396 | ENTX | Entera Bio Ltd. | 81.71M | 14.48% | 196,583 | 42.00K |
| 397 | OSTX | OS Therapies Incorporated | 80.84M | 0.83% | 197,252 | - |
| 398 | HRTX | Heron Therapeutics, Inc. | 79.57M | 2.54% | 943,243 | 150.71M |
| 399 | LONA | LeonaBio, Inc. | 79.19M | -2.99% | 6,170 | - |
| 400 | HYFT | MindWalk Holdings Corp. | 76.98M | 1.97% | 62,670 | 20.70M |
| 401 | GANX | Gain Therapeutics, Inc. | 75.07M | 2.33% | 242,280 | - |
| 402 | ELTX | Elicio Therapeutics, Inc. | 73.62M | 2.93% | 244,646 | - |
| 403 | ANVS | Annovis Bio, Inc. | 71.90M | 2.42% | 295,872 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 71.66M | 8.11% | 221,311 | 1.15M |
| 405 | XBIT | XBiotech Inc. | 70.73M | -0.43% | 25,819 | - |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 69.98M | 3.48% | 63,241 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 69.74M | 0.44% | 65,984 | - |
| 408 | IMA | ImageneBio, Inc. | 68.06M | 1.59% | 802 | 800.00K |
| 409 | EDSA | Edesa Biotech, Inc. | 66.69M | 0.40% | 21,111 | - |
| 410 | BYSI | BeyondSpring Inc. | 65.79M | - | 2,772 | 1.88M |
| 411 | CING | Cingulate Inc. | 65.45M | 3.57% | 105,890 | - |
| 412 | MNOV | MediciNova, Inc. | 62.98M | -2.32% | 13,362 | 596.64K |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 62.66M | 2.17% | 38,787 | - |
| 414 | EXOZ | eXoZymes, Inc. | 62.30M | -0.72% | 1,637 | -700.00 |
| 415 | VRXA | Veraxa Biotech AG | 59.77M | 0.85% | 112,487 | - |
| 416 | INKT | MiNK Therapeutics, Inc. | 59.14M | 4.95% | 6,112 | - |
| 417 | FLNA | Filana Therapeutics, Inc. | 57.97M | 3.45% | 98,358 | - |
| 418 | BOLD | Boundless Bio, Inc. | 57.06M | 1.20% | 90,517 | - |
| 419 | TCRX | TScan Therapeutics, Inc. | 56.31M | 2.57% | 75,930 | 9.14M |
| 420 | ATYR | aTyr Pharma, Inc. | 55.36M | 0.88% | 336,250 | 190.00K |
| 421 | CNTX | Context Therapeutics Inc. | 54.84M | 6.59% | 1,134,495 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 52.35M | -1.57% | 7,504 | 53.48M |
| 423 | IBO | Impact BioMedical Inc. | 51.92M | 1.16% | 19,305 | 39.00K |
| 424 | MREO | Mereo BioPharma Group plc | 50.92M | 5.98% | 432,303 | 500.00K |
| 425 | TIL | Instil Bio, Inc. | 50.86M | 0.54% | 3,815 | - |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 50.44M | 1.35% | 6,544 | - |
| 427 | PDSB | PDS Biotechnology Corporation | 49.74M | -0.31% | 322,269 | - |
| 428 | IMMP | Immutep Limited | 48.94M | -2.75% | 105,583 | 5.28M |
| 429 | LTRN | Lantern Pharma Inc. | 48.87M | 4.36% | 35,011 | - |
| 430 | KALA | KALA BIO, Inc. | 48.52M | 2.35% | 12,092 | - |
| 431 | MGX | Metagenomi Therapeutics, Inc. | 48.38M | 7.98% | 97,923 | 22.33M |
| 432 | VERU | Veru Inc. | 48.15M | 2.04% | 47,753 | 16.89M |
| 433 | ACTU | Actuate Therapeutics, Inc. | 47.37M | 1.02% | 9,667 | - |
| 434 | APLM | Apollomics, Inc. | 47.00M | -2.73% | 7,462 | 8.84M |
| 435 | HYPD | Hyperion DeFi, Inc. | 46.99M | 4.73% | 352,590 | 1.04M |
| 436 | RADX | Radiopharm Theranostics Limited | 46.59M | -8.78% | 29,297 | 10.86M |
| 437 | ELOX | Eloxx Pharmaceuticals, Inc. | 46.42M | -2.13% | 7,259 | - |
| 438 | RNXT | RenovoRx, Inc. | 44.20M | 5.39% | 342,563 | 1.49M |
| 439 | CRVO | CervoMed Inc. | 44.11M | -2.65% | 139,383 | 2.09M |
| 440 | INMB | INmune Bio Inc. | 41.47M | 4.70% | 879,579 | 50.00K |
| 441 | ESLA | Estrella Immunopharma, Inc. | 41.31M | 1.05% | 14,003 | - |
| 442 | GNTA | Genenta Science S.p.A. | 41.29M | 1.18% | 89,212 | - |
| 443 | TVGN | Tevogen Bio Holdings Inc. | 39.95M | - | 552 | - |
| 444 | GRCE | Grace Therapeutics, Inc. | 39.06M | 1.27% | 129,142 | - |
| 445 | ABVC | ABVC BioPharma, Inc. | 37.15M | 1.38% | 97,637 | 797.92K |
| 446 | NTRB | Nutriband Inc. | 36.71M | -0.33% | 11,229 | 1.80M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.84M | 2.36% | 13,894 | 4.71M |
| 448 | SNTI | Senti Biosciences Holdings, Inc. | 34.57M | 3.74% | 105,620 | 38.00K |
| 449 | LSTA | Lisata Therapeutics, Inc. | 30.87M | 0.30% | 1,815 | 170.00K |
| 450 | DARE | Daré Bioscience, Inc. | 30.56M | 2.00% | 14,695 | 1.16M |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 30.19M | 1.28% | 47,834 | 90.00K |
| 452 | NNVC | NanoViricides, Inc. | 30.07M | 1.54% | 74,959 | - |
| 453 | GRDX | GridAI Technologies Corp. | 30.01M | 4.16% | 16,703 | - |
| 454 | DYAI | Dyadic International, Inc. | 29.88M | 10.66% | 189,437 | 3.81M |
| 455 | PSTV | Plus Therapeutics, Inc. | 29.53M | 0.70% | 81,122 | 5.18M |
| 456 | LITS | Lite Strategy, Inc. | 29.44M | 5.87% | 80,499 | - |
| 457 | BRNS | Barinthus Biotherapeutics plc | 28.92M | -1.53% | 703 | 14.97M |
| 458 | SER | Serina Therapeutics, Inc. | 28.35M | 3.85% | 15,871 | 130.00K |
| 459 | VTGN | Vistagen Therapeutics, Inc. | 27.50M | 8.69% | 383,778 | 1.27M |
| 460 | KYNB | Kyntra Bio, Inc. | 27.37M | -2.59% | 1,717 | 7.44M |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 27.22M | 1.45% | 31,551 | - |
| 462 | IGC | IGC Pharma, Inc. | 27.04M | 3.17% | 180,172 | 1.11M |
| 463 | EVAX | Evaxion A/S | 26.10M | -0.35% | 31,660 | 7.53M |
| 464 | BCTX | BriaCell Therapeutics Corp. | 25.68M | 1.01% | 50,754 | - |
| 465 | QNTM | Quantum BioPharma Ltd. | 25.25M | -2.04% | 34,509 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 24.88M | -0.06% | 34,392 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 23.32M | -0.80% | 67,363 | -13.27K |
| 468 | TVRD | Tvardi Therapeutics, Inc. | 22.37M | 1.06% | 10,155 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 22.08M | 1.08% | 37,719 | 3.55M |
| 470 | LGVN | Longeveron Inc. | 21.97M | -3.22% | 149,864 | 1.22M |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.85M | 0.51% | 18,784 | 454.00K |
| 472 | PLUR | Pluri Inc. | 21.79M | -6.48% | 1,589 | 1.08M |
| 473 | PLRZ | Polyrizon Ltd. | 21.53M | 0.70% | 2,307 | - |
| 474 | ALLR | Allarity Therapeutics, Inc. | 21.00M | 3.94% | 64,355 | 345.00K |
| 475 | LPCN | Lipocine Inc. | 20.08M | 2.35% | 6,483 | 2.00M |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.06M | 1.64% | 1,914 | - |
| 477 | PTN | Palatin Technologies, Inc. | 19.66M | -1.66% | 1,702 | 12.88M |
| 478 | AEON | AEON Biopharma, Inc. | 18.94M | 4.32% | 15,601 | - |
| 479 | NCEL | NewcelX Ltd. | 18.85M | -1.38% | 1,116 | - |
| 480 | KTTA | Pasithea Therapeutics Corp. | 18.71M | 3.39% | 45,977 | - |
| 481 | MBRX | Moleculin Biotech, Inc. | 18.30M | 14.72% | 677,765 | - |
| 482 | CELU | Celularity Inc. | 17.95M | -6.79% | 129,051 | 26.55M |
| 483 | CVM | CEL-SCI Corporation | 17.83M | 4.68% | 47,632 | - |
| 484 | XCUR | Exicure, Inc. | 17.53M | 9.13% | 41,141 | 500.00K |
| 485 | HOWL | Werewolf Therapeutics, Inc. | 16.23M | - | 251,326 | 1.14M |
| 486 | TPST | Tempest Therapeutics, Inc. | 16.14M | 3.81% | 98,427 | - |
| 487 | MLEC | Moolec Science SA | 15.85M | -0.78% | 2,717 | 7.83M |
| 488 | GTBP | GT Biopharma, Inc. | 15.76M | 5.02% | 422,357 | - |
| 489 | QNCX | Quince Therapeutics, Inc. | 15.76M | -0.97% | 92,966 | - |
| 490 | ATOS | Atossa Therapeutics, Inc. | 15.67M | 2.82% | 162,109 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.51M | 4.74% | 7,353 | 152.72K |
| 492 | LNAI | Lunai Bioworks Inc. | 15.37M | -4.78% | 61,979 | 20.94K |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 15.32M | 2.37% | 62,471 | 5.61M |
| 494 | PASG | Passage Bio, Inc. | 14.95M | 7.62% | 102,218 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 14.20M | 1.98% | 24,062 | 225.00K |
| 496 | BIVI | BioVie Inc. | 13.95M | 3.93% | 16,579 | - |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | 13.49M | 0.32% | 2,668 | 1.99M |
| 498 | BCDA | BioCardia, Inc. | 13.42M | 8.26% | 971,735 | 3.00K |
| 499 | LEXX | Lexaria Bioscience Corp. | 13.32M | -1.74% | 20,540 | 368.00K |
| 500 | INAB | IN8bio, Inc. | 13.20M | -1.47% | 10,348 | - |